<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201009048974N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-21</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of Mindful Hypnotherapy on psychological aspects and severity of headache in patients with chronic migraine</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of hypnosis-based mindfulness therapy on psychological aspects and severity of headache in patients with chronic migraine</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>38</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61334</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be simple randomization method. the random unit is individuals. 38 patients with chronic migraine will be divided into intervention and control groups by Microsoft Excel software using Rand function. In this way, a table of random numbers will be prepared and the Randbetween function will be created and the patients will be divided into two groups of 19 people respectively, Blinding description: The outcome assessor in data collection after the intervention and the data analyst will be unaware of the objectives of the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic migraine headache.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Mindful Hypnotherapy. This treatment will be performed in 8 one-hour individual sessions according to the Elkins protocol. Intervention 2: Control group: At first, the control group does not receive any intervention and only the results of their evaluations, which are done by the relevant questionnaires, will be compared with the intervention group. At the end of the study, for all members of the control group, Mindful hypnotherapy intervention will be performed in 8 one-hour individual sessions according to the Elkins protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Participants' data will be shared in the SPSS file using by code of participants  (not using first and last name)

When:
Access to the data will be after the articles are published

To whom:
The data will be available only to researchers working in academic and scientific institutions

Conditions:
Request from the journals where the articles related to this research intend to be published.

Where to obtain:
By receiving confirmation via email to the main executor or executors of the project

How to obtain:
Send an email to the main executor or other executors of the project and receive written confirmation through them

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hassan Khazraee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>arabi St, Taleghani Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11111-11111</zip>
        <telephone>+98 21 2293 5548</telephone>
        <email>hassankhazraee@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hassan Khazraee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Arabi St, Taleghani hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>11111-11111</zip>
        <telephone>+98 21 2293 5548</telephone>
        <email>hassankhazraee@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having chronic migraine headaches according to the International Headache Committee (IHS) and the beta version of the Third International Classification of Headache Disorders (ICHD-3 beta)
Having informed consent to participate in the research and signing the informed consent form
Age range between 18 and 50 years
At least a diploma degree
Female gender</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having other chronic pain problems
Have a history of psychotherapy in the last 6 months
Participate in another psychological intervention simultaneously
Recent drugs abuse
Existence of diagnostic indicators or history of borderline personality disorder, psychosis or schizophrenia due to interference with hypnosis
History of epileptic seizures or facial nerve pain</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G43.701</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic migraine without aura, not intractable, with status migrainosus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Mindful Hypnotherapy. This treatment will be performed in 8 one-hour individual sessions according to the Elkins protocol.</i_keyword>
      <i_keyword>Control group: At first, the control group does not receive any intervention and only the results of their evaluations, which are done by the relevant questionnaires, will be compared with the intervention group. At the end of the study, for all members of the control group, Mindful hypnotherapy intervention will be performed in 8 one-hour individual sessions according to the Elkins protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Psychological inflexibility. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Psychological Inflexibility Pain Scale (PIPS).</prim_outcome>
      <prim_outcome>Pain Acceptance. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain acceptance questionnaire (CPAQ).</prim_outcome>
      <prim_outcome>Pain Anxiety. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain Anxiety Symptoms Scale (PASS-20).</prim_outcome>
      <prim_outcome>Pain Catastrophizing. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Pain Catastrophizing Scale  (PCS).</prim_outcome>
      <prim_outcome>Mindfulness. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Five Facet Mindfulness Questionnaire (FFMQ).</prim_outcome>
      <prim_outcome>Self-Compassion. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Self-Compassion Scale (SCS).</prim_outcome>
      <prim_outcome>Emotion Regulation. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Emotion Regulation Strategies Questionnaire (ERQ).</prim_outcome>
      <prim_outcome>Psychological Distress. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Kessler Psychological Distress Scale (K10).</prim_outcome>
      <prim_outcome>Headache related disability. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Headache related disability questionnaire (HDI).</prim_outcome>
      <prim_outcome>Headache intensity. Timepoint: In the per-intervention and post-intervention stages for 2 months. Method of measurement: Visual Analogue Scale (VAS), McGill Pain Questionnaire (MPQ), Blanchard headache diary.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-04</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Tehran, Ghods Town (West), between South Flamek and Zarafshan, Iran TV St. - Headquarters of the Ministry of Health, Treatment and Medical Education, Block A, 13th floor Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
